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Immediate Versus Delayed Insertion of the Levonorgestrel 
Intrauterine Device in Postpartum Adolescents: 
A Randomized Pilot Study
Reni Soon MD, MPH; Katie McGuire MD;, Jennifer Salcedo MD, MPH, MPP; 
and Bliss Kaneshiro MD, MPH
Abstract
This pilot study assessed the feasibility of conducting a larger randomized 
controlled trial comparing the proportion of adolescents using a levonorgestrel 
intrauterine device (LNG IUD) at six months postpartum when it is inserted 
immediately after vaginal delivery (within 10 minutes after placental expulsion) 
compared to insertion four to six weeks postpartum. Pregnant adolescents 
(14 to 19 years) who desired a LNG IUD for postpartum contraception were 
randomized to insertion of the LNG IUD either within 10 minutes of delivery of 
the placenta or at 4-6 weeks postpartum. Study follow-up visits were conducted 
at 4-6 weeks postpartum, 10 weeks postpartum, and 6 months postpartum. 
From November 2013 to June 2015, eleven adolescents were randomized - 
six participants to the immediate postpartum LNG IUD insertion group, and 
five to the delayed insertion group. All six women in the immediate insertion 
group had successful immediate postpartum insertion; two of five women in 
the delayed insertion group had an IUD inserted. At six months postpartum, 
four of six women in the immediate insertion group had a LNG IUD in place; 
of the five women in the delayed group, three did not have a LNG IUD in place 
and two were pregnant. The study was discontinued after 19 months because 
of suboptimal enrollment. Though insertion of a LNG IUD immediately after 
delivery is an appropriate option for some adolescents, a larger prospective 
study comparing immediate to delayed LNG IUD insertion is unlikely to be 
feasible at our institution.  
Keywords 
long-acting reversible contraception (LARC), adolescent contraception, 
postpartum contraception, intrauterine device (IUD)
Abbreviations
LARC – Long-acting reversible contraception
IUD – intrauterine device
LNG – levonorgestrel
OCPs – oral contraceptive pills
DMPA – Depot medroxyprogesterone acetate
UH – University of Hawai‘i
OB/GYN – Obstetrics and gynecology
Introduction
Immediate postpartum insertion of long acting reversible con-
traception (LARC) is increasingly recognized as a useful ap-
proach to reduce unintended pregnancies.1 Among adolescents, 
75% of pregnancies are unintended2 and one in five adolescent 
mothers becomes pregnant again within 12 months of delivery.3 
In Hawai‘i, 17% of all births among women age 15 to 19 years 
are repeat births.4 To avoid increasing the socioeconomic hard-
ship,5-8 and pregnancy complications9 associated with repeat 
adolescent births, access to immediate postpartum contraception 
is particularly important in this population.
 LARC methods, including the copper and levonorgestrel 
(LNG) intrauterine devices (IUDs) and the contraceptive im-
plant, are described as first-line contraceptives for adolescents 
and adults by the American College of Obstetricians and Gy-
necologists.10 LARC methods require little action on the part 
of the patient after insertion, resulting in typical-use effective-
ness of 99.8% in the first year of use.11,12 Women using the oral 
contraceptive pill, patch, and ring are 22 times more likely to 
become pregnant in the first year of use compared with women 
using a LARC method.13
 Programs most successful at reducing rapid repeat adoles-
cent pregnancy have generally included promotion of LARC 
methods.3,14,15 Immediate postpartum IUD insertion, defined as 
insertion of an IUD within ten minutes of placental delivery, 
has been studied in adult women. Insertion in this setting is 
convenient for the patient and the provider, bypasses many of the 
barriers that are present when women wait the standard four to 
six weeks following delivery for IUD insertion, and ensures that 
the woman is not pregnant at the time of insertion.  An increas-
ing number of studies have investigated immediate postpartum 
insertion of the LNG IUD,16-20 but most lack randomization 
and fail to provide adequate information on adolescents. Not 
only do adolescents disproportionately experience unintended 
pregnancy, but they also may be differently affected by fac-
tors like expulsion rates and the desire for reinsertion of the 
device compared to adults. Furthermore, adolescent mothers 
typically face more barriers to care following discharge from 
the hospital.21 
 The aim of this pilot study was to determine the feasibility 
of conducting a large randomized controlled trial comparing 
the proportion of adolescents using a LNG IUD at 6 months 
postpartum when it is placed within 10 minutes of delivery 
of the placenta following vaginal delivery (immediate inser-
tion) versus four to six weeks postpartum (delayed insertion). 
We also aimed to identify methodological challenges and the 
percent attrition in both study groups. Additional outcomes 
included patient satisfaction, expulsion, bleeding patterns, and 
breastfeeding rates.     
Materials and Methods
This prospective, randomized pilot study was conducted at 
Kapi‘olani Medical Center for Women and Children in Honolulu, 
Hawai‘i, which is the primary training site for the University of 
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Hawai‘i (UH) John A. Burns School of Medicine Department 
of Obstetrics and Gynecology (OB/GYN) residency program. 
We enrolled pregnant adolescents (14 to 19 years old) who 
planned to use a LNG-IUD after delivery and randomized 
participants to immediate postpartum or delayed insertion of 
the LNG-IUD. We excluded women with an allergy to the 
LNG-IUD; chlamydia or gonorrhea during pregnancy without 
a negative test-of-cure result; an anomaly distorting the uterine 
cavity; current cervical cancer; a desire for a repeat pregnancy 
within one year; plans to move from Oahu less than six months 
after delivery; a planned cesarean delivery; or a delivery at less 
than 34 weeks gestation. This study received approval from the 
Western Institutional Review Board. 
 Potential participants were identified either at their presenta-
tion to the labor and delivery suite or at their prenatal visits at 
the UH resident or faculty practice clinics. Potential participants 
were approached about the study at 24 weeks gestation or greater, 
and were assured that their care would not be affected whether 
they chose to participate in the study or not. If an antepartum 
patient expressed interest in enrolling, a notation was made 
in her chart. Patients were then screened for eligibility and 
enrolled in the study at the time of presentation to the labor 
and delivery suite. After consent was obtained, participants 
completed a demographic and medical information question-
naire. Study personnel placed one of the sequentially numbered, 
opaque sealed envelopes with the participant’s allocation as-
signment in the delivery room. A statistician not involved with 
the conduct of the study used a true random number generator 
to develop the 1:1 randomization scheme using block sizes of 
six. Subsequent exclusion criteria included: chorioamnionitis, 
postpartum hemorrhage, unanticipated cesarean delivery, and 
delivery at a time when a study investigator was unavailable. 
To limit post-randomization exclusions, the envelope with the 
participant’s allocation assignment was opened after delivery. 
If exclusion criteria were met after consent, the unopened 
envelope with the study allocation assignment was returned to 
the stack of envelopes to maintain sequential numbering.
 Patients randomized to immediate insertion had their proce-
dure performed within ten minutes of delivery of the placenta by 
study investigators or UH OB/GYN residents under the direct 
supervision of study investigators. Insertions were performed 
using a technique similar to that described by O’Hanley, et 
al,22 and Hayes, et al.16 After placental expulsion and uterine 
massage, the IUD was removed from the inserter and placed by 
hand at the uterine fundus. The other hand palpated the fundus 
abdominally to ensure that the hand inserting the IUD was at 
the fundus. If placement by hand was not possible due to patient 
discomfort, ring forceps were used to insert the IUD using a 
technique described by Speroff and Mishell23 and employed 
in the study by Dahlke, et al.18 Strings were trimmed three 
centimeters from the external os. While ultrasound was not a 
routine part of the study protocol, use was left to the discretion 
of the treating physicians. Participants randomized to delayed 
insertion had the LNG IUD placed four to six weeks follow-
ing delivery using the standard technique by their obstetrician 
(residents with faculty supervision or faculty). 
 Study visits were scheduled at four to six weeks, ten weeks, 
and six months postpartum. Participants were given a $5 online 
gift card  at each study visit as compensation for their time. 
A study coordinator scheduled the four to six week follow up 
visit prior to hospital discharge. At each study visit, a pelvic 
exam was performed and if the IUD strings were not visible, 
an ultrasound was performed to confirm intrauterine position. 
If the IUD was visible in the cervix, it was considered an 
expulsion and was removed. Any patient who experienced an 
expulsion during the six-month study period was counseled 
about all contraceptive options and was given the option of 
insertion of another LNG IUD at no cost. Participants were 
also asked about bleeding, cramping, fever, pain, sexual activ-
ity, and breastfeeding. Participants rated their satisfaction with 
the LNG IUD on a 10-cm Visual Analog Scale, anchored at 0 
being very unsatisfied and 10 being very satisfied. Participants 
who wished to have the LNG IUD removed could return at any 
time during the 6-month postpartum study period to do so at 
no cost. 
 Three phone calls were made to participants who did not 
return for their follow up visits. If a participant declined an 
in-person visit, phone follow-up was done and participants 
were asked all the questions that would have been asked in 
an in-person visit, as well as additional questions to assess the 
likelihood of IUD expulsion. The patient’s medical record was 
reviewed to determine if she sought care related to the IUD or 
had a postpartum complication.      
 The sample size of this pilot study was estimated to deter-
mine feasibility of a larger study. We used principles outlined 
by Hertzog24 to estimate that a sample size of 30 participants, 
15 in each group, would be needed to adequately describe re-
cruitment, post-enrollment exclusion, and attrition to determine 
the feasibility of a larger study. With this sample size and an 
observed 15% attrition rate we could be 68% confident that our 
estimates would be accurate within 8 percentage points.
 The study was discontinued prior to meeting our sample size 
goal due to suboptimal enrollment. We had planned to compare 
the proportion of participants who continued to use the LNG IUD 
at six months with Chi-square or Fisher’s exact tests. Patients 
who experienced an expulsion but had an IUD reinserted would 
have been classified as using an IUD, and we were planning to 
analyze using intention-to-treat principles. However, because 
the study had to be discontinued, the participants and their 
follow-up are described. 
Results
From November 2013 to June 2015, 18 women verbally agreed 
to participate. Seven women were excluded prior to random-
ization – three women had a cesarean section, one developed 
chorioamnionitis, one delivered at less than 34 weeks gestation, 
one declined insertion of an IUD, and for one participant the 
reason for exclusion was not recorded. Of the eleven women 
remaining, six were randomized to immediate insertion and 
five to delayed insertion. 
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 Patient demographic factors are described in Table 1. The 
mean age of participants was 18.4 years. Six participants had 
been previously pregnant, and three had experienced a prior 
delivery. Five of the participants had never used a form of 
contraception; four had used condoms; and four had used a 
short-term hormonal contraceptive. 
 All of the participants and their course through the study 
are detailed in Table 2 and Figure 1. Of the six participants 
randomized to immediate IUD insertion, all six had success-
ful insertion of their IUDs immediately postpartum (100% 
insertion), and four (67%) had the IUD in place at six months 
postpartum. One participant in the immediate insertion group 
had an IUD expulsion prior to her 4-6 week follow-up visit and 
did not desire IUD replacement. She was unable to be reached 
for the 10-week follow-up and 6-month follow-up visits. The 
other participant randomized to immediate insertion requested 
removal of her IUD at her 10-week visit because of some dis-
comfort she attributed to the IUD and requested a contraceptive 
injection. She could not be reached for her 6-month follow-up.
 Of the five participants randomized to delayed IUD insertion 
at follow-up, only two had an IUD inserted (40% insertion). At 
six months, one of the two had had her IUD removed a month 
after insertion and was pregnant; the other was unable to be 
reached. Of the three participants randomized to delayed inser-
tion who never had an IUD inserted, one of them presented to the 
labor and delivery suite eleven months postpartum with a term 
pregnancy, and two declined IUD insertion at their follow-up 
visits. At six months postpartum, three of the five participants 
randomized to delayed IUD insertion did not have IUDs in 
place and two of the three were pregnant.
 Some of the participants followed up at outside facilities 
instead of the resident clinic where study visits were conducted. 
Of the 18 follow-up visits among the immediate insertion 
participants, 14 were completed (78%); of the 15 follow-up 
visits among delayed insertion participants, six (40%) were 
Table 1. Participant Characteristics
Characteristic
Immediate Postpartum 
Group 
(n=6)
Delayed 
Group
(n=5)
Mean age (years  ± SD) 18.33 ± 1.03 18.40 ± 0.89
Race*
 Non-Hispanic white 1 (17%) 1 (20%)
 Non-Hispanic black 1 (17%) 0 (0%)
 Asian 1 (17%) 1 (20%)
 Native Hawaiian/Pacific Islander 4 (67%) 4 (80%)
Previously used contraception** 3 (50%) 3 (60%)
Previously used IUD or implant 0 (0%) 0 (0%)
Previously pregnant 1 (17%) 5 (100%)
Previous delivery 0 (0%) 3 (60%)
*Participants could identify more than one race
**Contraceptive methods asked about: IUD, implant, injection, oral contraceptive, 
patch, ring, condoms
completed, but two were completed over the phone and two were 
completed at an outside facility. Because of this, we have data 
on contraceptive method at the time of the visit but do not have 
data for most participants on bleeding patterns, breastfeeding, 
sexual activity or contraceptive method satisfaction. Therefore 
we are unable to comment on any differences in these outcomes 
between groups. Of the six participants who had follow-up 
visits in the resident clinic, five were in the immediate inser-
tion group. Four of these five expressed a preference for IUD 
insertion immediately postpartum over delayed insertion and 
rated their experience as “very satisfied.” One participant who 
had an immediate insertion and had an IUD expulsion prior to 
her 4-6 week visit stated she would prefer delayed IUD inser-
tion over immediate. One participant in the delayed insertion 
group, and the only one from that group who followed-up in 
the resident clinic and therefore the only one who was asked 
the question, stated she did not have a preference for immediate 
or delayed IUD insertion.
Discussion
Although we found that a larger randomized controlled trial 
comparing immediate to delayed postpartum LNG IUD insertion 
among adolescents is not feasible at our institution, we describe 
a small cohort of adolescent women in Honolulu who appear 
to have benefitted from immediate postpartum IUD insertion. 
Of the women randomized to immediate insertion, four of the 
six had an IUD in place at six months postpartum. Four of the 
six women expressed a preference of immediate insertion over 
delayed insertion and were “very satisfied” with their experi-
ence. Of the five women randomized to delayed insertion, three 
of them did not have an IUD in place at six months postpartum 
and two of the women had again become pregnant.  Our find-
ings are consistent with other studies in adult women showing 
that many women who have immediate postpartum insertions 
of a LNG IUD are using an IUD at six months postpartum.18-20 
Most of these studies also report high patient satisfaction with 
immediate postpartum placement. 
 Suboptimal enrollment and difficulty in following up with 
participants precluded conduct of any of the planned analyses. 
While LARC use among adolescents is increasing, overall rates 
of use are still low and most of the increase seen has been in the 
use of the contraceptive implant. In an analysis of contracep-
tive method use among sexually active women age 15-19 years 
from 2011-2015, 2.8% had used an IUD (increase from 2.5% 
in 2006-2010) and 3.0% had used an implant (increased from 
0.6% in 2006-2010).25 Our suboptimal enrollment reflects this 
overall low rate of IUD use among adolescents. In addition, 
follow-up with our adolescent participants was challenging. 
Only 78% of potential follow-up visits were conducted in the 
immediate insertion group compared to 40% in the delayed 
insertion group. While it is not surprising that the participants 
who received the intervention were more likely to follow-up, 
this leads to ascertainment bias in addition to poor overall 
obtainment of outcome data.
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Table 2. Study Participants and Follow-up
Age Pregnancy history
Previous birth 
control used
4-6 wk f/u – 
IUD in place?
10 wk f/u – IUD 
in place?
6 mo f/u – IUD 
in place?
IUD in place at 
4-6 weeks
IUD in place at 
6 months
Preference 
for timing of 
IUD placement 
(asked at all f/u 
visits)
Immediate insertion group
19 G1P0 None
No – expulsed. 
Did not want 
replacement
Unable to 
contact
Unable to 
contact No Unknown Delayed
19 G1P0 OCPs Yes Yes Yes Yes Yes Immediate for all 3 visits
19 G2P0 None Yes Yes Yes Yes Yes Immediate for all 3 visits
17 G1P0 None Yes Unable to contact
Yes (visit was 
at 9 months 
postpartum) 
Yes Yes
Visit was at out-
side facility and 
was not asked
19 G1P0 Condoms Yes Yes Yes Yes Yes Immediate for all 3 visits
17 G1P0 Condoms, DMPA Yes
Requested IUD 
removal; got 
DMPA
Unable to 
contact Yes Unknown
Immediate for 2 
visits
Delayed insertion group
18 G2P1 Condoms, OCPs IUD inserted 
Unable to 
contact
Unable to 
contact Yes Unknown “Do not care”
17 G2P1 Condoms IUD inserted at outside facility
Unable to 
contact
Presented to 
outside facility 
for pregnancy 
test (positive). 
Stated had 
IUD removed 
1 month after it 
was placed
Yes No Was not asked
19 G2P0 None Unable to contact
*Stated she 
received DMPA 
injection post-
partum and was 
not sure what 
method she 
wanted to use
*Stated she did 
not have an 
IUD and was 
not sure what 
method she 
wanted to use
No No Was not asked
19 G3P2 DMPA No f/u, but 11 mos later admitted to hospital in labor with another full-term pregnancy No Was not asked
19 G2P0 None
No. Stated she 
wanted the 
contraceptive 
implant but 
never returned
Unable to 
contact
Unable to 
contact No Unknown Was not asked
*Follow-up by phone
Abbreviations: G=gravidity (number of pregnancies), P=parity (number of deliveries), DMPA=Depot medroxyprogesterone acetate (contraceptive injection), 
OCPs=oral contraceptive pills 
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Figure 1. Study Participants and Follow-up
 Despite the challenges of this study, the randomized controlled 
study design is critical to examining whether adolescents benefit 
from access to immediate postpartum IUD. While one cohort 
study of 82 adolescent (13-22 year-old) women who chose 
immediate postpartum IUD insertion found that 71% were still 
using an IUD at six months postpartum,20 cohort studies are 
subject to selection bias. Unrecognized differences between 
patients who choose immediate insertion versus women who 
choose standard delayed insertion can affect outcomes. In ad-
dition, a healthcare provider may be more likely to recommend 
immediate postpartum insertion to a patient thought to be at 
higher risk of short interval pregnancy or poor follow-up. Ways 
to mitigate challenges in a study such as this may include use 
of a closed healthcare system, higher compensation for study 
visits, and alternative methods of follow-up such as text mes-
saging or online surveys. 
 At our institution in Honolulu, adolescents are offered im-
mediate postpartum IUD insertion because follow-up rates for 
postpartum visits are low in this group. While we found that a 
larger randomized controlled trial to examine this question is not 
feasible at our institution, we were able to describe a small group 
of local adolescents who benefitted from immediate postpartum 
IUD placement. In contrast, of the five adolescents who were 
randomized to delayed IUD insertion, two were pregnant again 
by six months after their delivery. Immediate postpartum IUD 
insertion may be an effective way to increase use of a highly 
effective contraceptive method in a group of young women at 
high risk for unintended pregnancy. 
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